Try GOLD - Free

Bio Spectrum Magazine - BioSpectrum India Dec 2024

filled-star
Bio Spectrum

Go Unlimited with Magzter GOLD

Read Bio Spectrum along with 10,000+ other magazines & newspapers with just one subscription  

View Catalog

1 Month

$14.99

1 Year

$149.99

$12/month

(OR)

Subscribe only to Bio Spectrum

Buy this issue: BioSpectrum India Dec 2024

1 issues starting from BioSpectrum India Dec 2024

12 issues starting from BioSpectrum India Dec 2024

Buy this issue

$0.99

1 Year

$10.99

Please choose your subscription plan

Cancel Anytime.

(No Commitments) ⓘ

If you are not happy with the subscription, you can email us at help@magzter.com within 7 days of subscription start date for a full refund. No questions asked - Promise! (Note: Not applicable for single issue purchases)

Digital Subscription

Instant Access ⓘ

Subscribe now to instantly start reading on the Magzter website, iOS, Android, and Amazon apps.

Verified Secure

payment ⓘ

Magzter is a verified Stripe merchant.

In this issue

BioPharma’s Transformative & Strategic OUTLOOK 2025 The Indian biopharma industry witnessed notable transformative developments and announcements, marked by innovation, regulatory advancements, and market expansion this year. From achieving global recognition in biosimilars to advancing biomanufacturing capabilities and precision therapeutics, the sector has solidified its role as a key player in the global pharmaceutical landscape. This progress underscores India’s strategic focus on leveraging its robust infrastructure, skilled talent pool, and government support to meet the evolving demands of the healthcare industry. Key developments in 2024 include an increase in biosimilar approvals, enhanced collaborations for biologics and vaccines, and a focus on potential investments in cutting-edge technologies like Artificial Intelligence (AI), continuous manufacturing, and automation through biofoundries. Looking ahead, the industry is well-positioned to align with emerging trends that are shaping the global biopharma landscape for 2025 and beyond.These include the growing emphasis on precision medicine, a shift towards sustainablebiomanufacturing practices, and an increase in demand for advanced therapies such as cell and gene therapies. With over $200 billion worth of biologic patents set to expire by 2030, Indiancompanies are poised to play a pivotal role in driving the next wave of innovation and accessibilityin biologics and biosimilars.

Bio Spectrum Magazine Description:

India's leading publication that covers the business of bio-technology. With comprehensive analyses of policy issues, products and services across the bio-pharma, bio-informatics, bio-infrastructure and bio-agriculture segments, it is the industry's most authoritative source of information.

Recent issues

Special Issues

  • March 2013

    March 2013

Related Titles

Popular Categories